Researchers at Rutgers Robert Wood Johnson Medical School have reported the first instance of COVID-19 triggering a recurrence of Guillain–Barré Syndrome – a rare disorder where the body’s immune system attacks nerves and can lead to respiratory failure and death. While there have been several reports of Guillain–Barré Syndrome following COVID-19, this is the first in which COVID-19 actually triggered a recurrence of the condition – in a 54-year-old man who had suffered with Guillain–Barré Syndrome twice and had a third occurrence after testing positive for COVID-19, according to the Rutgers case report published in the journal Pathogens. To read the full story.
- Marijuana Component Offers Opioid Alternative by Effectively Treating Dental Pain.
- Join NJ ACTS Special Populations Core Seminar on December 5th at 12pm
- Neighborhood Stress Can Heighten Levels of Maternal Sex Hormones During Pregnancy.
- RBHS 10th Anniversary: A Decade of Commitment to Community Health.
- Exposure to Air Pollution In Utero May Affect Reproductive System Development.